Android Apple

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Analysts Just Slashed This Year's Revenue Estimates By 12%

By Yahoo! Finance   |   4 months ago
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Analysts Just Slashed This Year's Revenue Estimates By 12%

Analysts have revised down their revenue forecasts for Agios Pharmaceuticals, Inc. It is now predicted to reach US$36m in 2024, a 21% improvement. Despite this, analysts have not changed the price target of US$52.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.